Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
Konstantinos N. Aronis(University of Pittsburgh Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Pantel Vokonas(VA Boston Healthcare System), Reena Berman(Beth Israel Deaconess Medical Center), Elías Delgado(Hospital Universitario Central de Asturias), María U. Moreno(Instituto de Salud Carlos III), Avron Spiro(Boston University), José María Moreno‐Navarrete(Instituto de Salud Carlos III), Ayse Sahin-Efe(Beth Israel Deaconess Medical Center), John P. Chamberland(Beth Israel Deaconess Medical Center), José Manuel Fernández‐Real(Universitat de Girona), J de la Hera(Hospital Universitario Central de Asturias), Wifredo Ricart(Hospital Universitari de Girona Doctor Josep Trueta)
Cited by 111
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k